Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
Investing.com - P3 Health Partners reported on Monday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
P3 Health Partners announced earnings per share of $-0.27 on revenue of $248.26M. Analysts polled by Investing.com EPS of $-0.21 on revenue of $243.5M.
P3 Health Partners 's are down 81% and is trading at $4.94 , still down 70.53% from its 52 week high of $16.73 set on Monday, December 6, 2021.
P3 Health Partners shares gained 0.20% to trade at $4.94 in after-hours trade the report.
P3 Health Partners follows other major Healthcare sector earnings this month
P3 Health Partners's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar